MHRA — 20 things I got wrong before I got it right
Posting this as a discussion rather than a claim: MHRA — 20 things I got wrong before I got it right.
Why the monthly pricing tracker works, and the rule that makes it work.
Members post the pharmacy, the product, the month and the price they actually paid — not an advertised offer, not a first-month discount. No links of any kind are permitted, which removes the entire incentive to post anything other than what happened.
The result is that the spread between pharmacies in a given month is visible, and it is consistently larger than people expect. That single table has saved members here more money than every other thread on the board combined, and it survives only because the no-links rule is enforced without exception.
The two routes, described separately, because mixing them is where most of the confusion here starts.
The NHS route in England runs through specialist weight management services commissioned by your ICB. Criteria, waiting times and what happens at discharge are all local decisions, which is why a confident answer from somebody in a different area may be wrong for you.
The private route is an independent transaction: a consultation, a prescription and a pharmacy price. It does not affect your position on any NHS list and it is not a shortcut through one. Both are legitimate; they are simply not the same pathway and they do not connect.
The scheme cap in Ireland was the single most useful thing I learned in a year of reading this board.
Ask me anything specific. Anything general I will probably get wrong.
best — the order this archive was captured in
Discharge at goal, which nobody warns people about.
Specialist services in England are commissioned to deliver a defined intervention. Reaching goal is a successful outcome and it typically ends with discharge back to primary care. Whether prescribing continues after that is a local decision that varies, and plenty of members here have discovered it at the point of discharge rather than at the start.
The useful thing to do is ask early: what happens when I finish, and does prescribing continue in primary care in this area. Ask it in writing, keep the answer, and you will at least know which conversation you are heading for.
Discharge from a specialist service at goal is a normal end point of that pathway. Whether prescribing continues in primary care afterwards is a local decision and is worth asking about at the start rather than at the end.
Discharged at goal back to the GP, who would not continue it. Nobody had mentioned that this was how it ends.
In England, specialist weight management services are commissioned locally, so eligibility criteria and waiting times differ by ICB. There is no single national threshold to quote.
tier 3 waiting lists are measured in years, not months
Cosigning on discharge at goal. It catches people who have done everything right and did not know it was coming.
the Irish scheme cap is the single most useful fact in this board
Scotland, Wales and Northern Ireland have their own arrangements. An answer that begins with "in England" should say so, and most of the confusion here comes from answers that do not.
Pharmacy pricing on a private prescription is set by the pharmacy. The spread between them in a given month is routinely substantial, which is why a tracker built from member reports is more useful than any headline.
Correction: that threshold is your ICB’s, not a national one. They differ and they change by year.
Same. My ICB threshold was different from the neighbouring one and nobody could tell me why.
A private prescription is an independent route: it does not affect NHS list position, and it is not a step in the same pathway.
Which nation, and which ICB if you are in England?
How long have you been on the list, and from what date?
Four pharmacies, four prices, same product, same month. The spread was larger than I expected and none of them were the headline offer.
private and NHS pathways are not a ladder, they are separate routes
Concentrations can differ between products and between pharmacies. Switching mid-titration means redoing the arithmetic rather than carrying the old unit count across.
Small fix — that is the Scottish pathway. The post is asking about England and the answer is different.
Have you seen the current threshold published by your ICB?
Referral link removed and the post left up. No links of any kind here, and that rule is not negotiable.
Supply notices from the regulator describe expected availability at a national level. They do not predict what any individual pharmacy has on the shelf next week.
Pharmacy names are fine in pricing posts; staff names are not.
the price difference between pharmacies this month is genuinely large
keep every letter, the dates matter later